Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: PawPr who wrote (730)	6/30/1998 3:16:00 PM
From: Mark Oliver	Read Replies (1) of 965

Centocor Inc. (CNTO) 37 +7/16: Lehman Brothers continues to rate biopharmaceutical company issue a "buy" as FDA has yet to act on panel recommendation for CNTO's Avakine drug; possible that FDA could respond with a "complete review" letter as opposed to an "approval letter" in which case it could create price weakness in the stock; thinks investors should take this opportunity to aggressively add to portfolio..... What is a "complete review" letter? Would this be just a delay, or a rejection of the drug? Regards, Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next